Skip to main content

Table 1 Cause-specific survival: invasive Melanoma in Queensland (1995–2008, follow-up to 2010)

From: Prognostic survival model for people diagnosed with invasive cutaneous melanoma

  Total 1 year survival 5 year survival 10 year survival
Total 28,654 (100%) 99.1 95.0 92.6
Gender     
 Male 16,269 (57%) 98.9 93.8 90.8
 Female 12,385 (43%) 99.4 96.5 94.8
Age group (years)a     
 20-39 4,958 (17%) 99.8 97.4 96.1
 40-59 10,814 (38%) 99.5 96.5 94.4
 60-69 5,405 (19%) 99.1 94.6 91.7
 70-79 5,006 (17%) 98.7 92.0 87.9
 80-89 2,471 (9%) 97.5 88.6 85.2
Thicknessa     
 <=0.50 mm 12,641 (44%) 100 99.6 99.0
 0.51-1.00 8,107 (28%) 99.9 97.9 96.2
 1.01-1.50 2,487 (9%) 99.2 93.1 88.3
 1.51-2.00 1,386 (5%) 98.8 87.9 80.3
 2.01-4.00 2,234 (8%) 97.3 79.6 70.8
 4.01+ 1,170 (4%) 92.9 67.8 61.4
 Unknownb 629 (2%) 91.5 82.6 78.6
Body site     
 Scalp 565 (2%) 96.2 78.8 69.3
 Face/Lip/Eyelid 2,221 (8%) 99.0 94.5 90.4
 Ear/Neck 1,741 (6%) 98.9 93.4 90.6
 Chest/Axilla 1,435 (5%) 99.2 96.0 94.0
 Abdomen + Hip 791 (3%) 98.7 93.7 90.7
 Back/Buttocks 8,046 (28%) 99.5 95.2 92.8
 Upper arm/Forearm/Hand/Finger/sb.hand 3,644 (13%) 99.5 96.6 95.4
 Foot/sb. foot/heel/toec 384 (1%) 97.4 87.7 79.6
 Thigh/leg/ankle 5,961 (21%) 99.5 96.5 94.7
 Shoulder 2,452 (9%) 99.5 96.0 93.7
 Unknownb 1,414 (5%) 96.4 92.0 90.2
Morphology     
 Superficial spreading melanoma 16,229 (57%) 99.7 97.3 95.7
 Nodular melanoma 2,415 (8%) 96.2 79.0 73.1
 Malignant melanoma in junctional naevus 654 (2%) 99.7 98.0 97.1
 Lentigo Maligna melanoma 1,688 (6%) 99.8 97.4 95.6
 Acral lentiginous melanoma 144 (<1%) 97.9 85.5 80.2
 Other specified melanoma 1,015 (4%) 97.5 87.6 79.8
 Malignant melanoma NOS 6,509 (23%) 98.9 95.2 92.7
Ulceration     
 No ulceration 17,110 (60%) 99.7 97.3 95.5
 Known ulceration 2,627 (9%) 95.4 77.0 70.7
 No mention on pathologyb 8,917 (31%) 99.1 95.5 93.1
Clarks level     
 Into papillary dermis 15,488 (54%) 99.9 99.4 98.5
 Filling papillary dermis 6,164 (22%) 99.6 95.3 92.7
 Into reticular dermis 5,584 (19%) 98.0 86.6 80.3
 Into subcutaneous fat 715 (3%) 93.4 70.0 60.7
 Unknownb 703 (2%) 92.4 80.9 73.9
Positive nodes     
 None 28,421 (99%) 99.3 95.4 93.0
 At least one 229 (<1%) 75.2 43.6 37.5
Metastasis     
 No 28,506 (99%) 99.3 95.3 92.9
 Yes 148 (<1%) 68.7 39.4 27.6
  1. Note: aModeled as a continuous variable in the prognostic model.
  2. bActual values for missing data were estimated in the modeling process using multiple chained imputation.
  3. csb = subungal; NOS = Not otherwise specified.